Fig. 3
From: Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors
Virus-associated prediction of immunotherapy efficacy measured by disease control rate (DCR) and risk ratio (RR), across different virus types, tumor types, and immunotherapy strategies.
